|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
DK1610787T3
(da)
*
|
2003-03-28 |
2008-06-02 |
Nycomed Gmbh |
Synergistisk kombination der omfatter roflumilast og et antikolinergt middel der er valgt blandt tiotropiumsalte til behandling af respiratoriske sygdomme
|
|
CA2522666A1
(en)
*
|
2003-04-18 |
2004-10-28 |
Pharmacia & Upjohn Company Llc |
Combination therapies for chronic obstructive pulmonary disease (copd)
|
|
UA83041C2
(ru)
*
|
2003-05-22 |
2008-06-10 |
Нікомед Гмбх |
Композиция, которая включает ингибитор pde4 и ингибитор pde5
|
|
WO2005013993A1
(en)
*
|
2003-07-29 |
2005-02-17 |
Boehringer Ingelheim International Gmbh |
Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders
|
|
EP1504756A1
(en)
*
|
2003-08-06 |
2005-02-09 |
Kyowa Hakko Kogyo Co., Ltd |
Medicament compositions comprising a heterocyclic compound and an anticholinergic
|
|
ES2381116T3
(es)
*
|
2004-02-06 |
2012-05-23 |
Meda Pharma Gmbh & Co. Kg |
Combinación de anticolinérgicos e inhibidores de fosfodiesterasa tipo 4 para el tratamiento de enfermedades respiratorias
|
|
WO2005074983A2
(en)
*
|
2004-02-06 |
2005-08-18 |
Meda Pharma Gmbh & Co. Kg |
Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
|
|
ES2413011T3
(es)
|
2004-02-06 |
2013-07-15 |
Meda Pharma Gmbh & Co. Kg |
Combinación de anticolinérgicos y glucocorticoides para el tratamiento a largo plazo de asma y EPOC
|
|
CA2553369A1
(en)
*
|
2004-02-20 |
2005-09-01 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions based on anticholinergics and pegsunercept
|
|
US7507745B2
(en)
|
2004-02-20 |
2009-03-24 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
|
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
AU2005247104B2
(en)
*
|
2004-05-31 |
2010-11-11 |
Laboratorios Almirall, S.A. |
Combinations comprising antimuscarinic agents and beta-adrenergic agonists
|
|
US20060079544A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Boehringer Ingelheim International Gmbh |
Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
|
|
RU2420285C2
(ru)
|
2005-03-16 |
2011-06-10 |
Меда Фарма Гмбх Унд Ко.Кг |
Комбинация r,r-гликопирролата и монтелукаста для лечения респираторных заболеваний и фармацевтическая композиция на ее основе
|
|
US8012971B2
(en)
*
|
2005-04-28 |
2011-09-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
Therapeutic agent for chronic obstructive pulmonary disease
|
|
DE102005035112A1
(de)
*
|
2005-07-27 |
2007-02-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
|
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス，インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
AU2006308889A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
GABA receptor mediated modulation of neurogenesis
|
|
DK2098248T3
(da)
|
2005-12-21 |
2012-09-17 |
Meda Pharma Gmbh & Co Kg |
Kombination af anticholinergika, glucocorticoider og beta2-agonister til behandling af inflammatoriske sygdomme
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
EP1905440A1
(de)
*
|
2006-09-06 |
2008-04-02 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
EP3090999A1
(en)
*
|
2009-06-18 |
2016-11-09 |
Concert Pharmaceuticals Inc. |
Deuterated isoindoline-1, 3-dione derivatives as pde4 and tnf-alpha inhibitors
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
WO2013106547A1
(en)
|
2012-01-10 |
2013-07-18 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|